Earnings Feed
Start Free
Moderna, Inc.·4

Feb 25, 4:49 PM ET

Hoge Stephen 4

4 · Moderna, Inc. · Filed Feb 25, 2026

Insider Transaction Report

Form 4
Period: 2026-02-23
Moderna, Inc.MRNA
Hoge Stephen
President
Transactions
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-02-23$19.15/sh+111,679$2,138,653→ 1,569,106 total
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-02-23$19.15/sh+48,330$925,519→ 1,617,436 total
  • Sale

    Common Stock

    [F1]
    2026-02-23$48.84/sh−160,009$7,814,840→ 1,457,427 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    [F1][F3]
    2026-02-23−111,679→ 111,678 total
    Exercise: $19.15Exp: 2026-08-10→ Common Stock (111,679 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    [F1][F3]
    2026-02-23−48,330→ 48,330 total
    Exercise: $19.15Exp: 2026-08-10→ Common Stock (48,330 underlying)
Holdings

  • Common Stock

    (indirect: By LLC)
    4,116

  • Common Stock

    [F2]
    (indirect: By Trust)
    151,933
Footnotes (3)
  • [F1]The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on November 13, 2025.
  • [F2]These shares are owned directly by a trust for the benefit of Dr. Hoge's spouse and children, of which his spouse is a trustee. The reporting person disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose.
  • [F3]This option is fully vested and exercisable.
Signature
/s/ James Dillon, as Attorney-in-Fact|2026-02-25

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT